Study: Cannabis Terpenes have “Anti-Inflammatory, Antioxidant, Analgesic, Anticonvulsive, Antidepressant, Anxiolytic, Anticancer, Antitumor, Neuroprotective, Anti-Mutagenic, Anti-Allergic, Antibiotic and Anti-Diabetic Attributes”

A new study has found that cannabis terpenes have attributes that are “anti-inflammatory, antioxidant, analgesic, anticonvulsive, antidepressant, anxiolytic, anticancer, antitumor, neuroprotective, anti-mutagenic, anti-allergic, antibiotic and anti-diabetic”.

The study was published by the European Journal of Medicinal Chemistry. It’s abstract starts by stating that “Cannabaceae plants Cannabis sativa L. and Humulus lupulus L. are rich in terpenes – both are typically comprised of terpenes as up to 3-5% of the dry-mass of the female inflorescence.” Some terpenes “are relatively well known for their potential in biomedicine and have been used in traditional medicine for centuries, while others are yet to be studied in detail.”

With that in mind, “The current, comprehensive review presents terpenes found in cannabis and hops.” They found that “Terpenes’ medicinal properties are supported by numerous in vitro, animal and clinical trials and show anti-inflammatory, antioxidant, analgesic, anticonvulsive, antidepressant, anxiolytic, anticancer, antitumor, neuroprotective, anti-mutagenic, anti-allergic, antibiotic and anti-diabetic attributes, among others.”

Researchers state that “Because of the very low toxicity, these terpenes are already widely used as food additives and in cosmetic products. Thus, they have been proven safe and well-tolerated.”

More information on this study can be found by clicking here.

The post Study: Cannabis Terpenes have “Anti-Inflammatory, Antioxidant, Analgesic, Anticonvulsive, Antidepressant, Anxiolytic, Anticancer, Antitumor, Neuroprotective, Anti-Mutagenic, Anti-Allergic, Antibiotic and Anti-Diabetic Attributes” appeared first on TheJointBlog.

from https://thejointblog.com/study-cannabis-terpenes-have-anti-inflammatory-antioxidant-analgesic-anticonvulsive-antidepressant-anxiolytic-anticancer-antitumor-neuroprotective-anti-mutagenic-anti-allergic-antibiotic/…

Study: Cannabis Can Help Treat Schizophrenia, Offering “a Fresh Start and Newfound Hope”

According to a new study published by the open access journal Medicines, and published online by the National Institute of Health, cannabis “can be used as a treatment for schizophrenia… offering a fresh start and newfound hope”.

According to the study’s abstract, “Approximately 0.5% of the population is diagnosed with some form of schizophrenia, under the prevailing view that the pathology is best treated using pharmaceutical medications that act on monoamine receptors.” For the study, researchers reviewed “evidence on the impact of environmental forces, particularly the effect of autoimmune activity, in the expression of schizophrenic profiles and the role of Cannabis therapy for regulating immunological functioning.”

“A review of the literature shows that phytocannabinoid consumption may be a safe and effective treatment option for schizophrenia as a primary or adjunctive therapy”, states the study. “Emerging research suggests that Cannabis can be used as a treatment for schizophrenia within a broader etiological perspective that focuses on environmental, autoimmune, and neuroinflammatory causes of the disorder, offering a fresh start and newfound hope for those suffering from this debilitating and poorly understood disease.”

The study was conducted at the University of New Mexico, with researchers from both the Department of Psychology and the Department of Economics.

The full study can be found by clicking here.

The post Study: Cannabis Can Help Treat Schizophrenia, Offering “a Fresh Start and Newfound Hope” appeared first on TheJointBlog.

from https://thejointblog.com/study-cannabis-can-help-treat-schizophrenia-offering-a-fresh-start-and-newfound-hope/…

It’s Official: North Dakota Marijuana Legalization Initiative Placed on November Ballot

An initiative to legalize marijuana in North Dakota has officially qualified for the November general election ballot.

According to the North Dakota secretary of state’s office, Legalize ND submitted more than the 13,500 valid signatures required to place their marijuana legalization initiative on the November 6 ballot.

The proposal, if passed, would give North Dakota one of the least restrictive legalization laws in the country. It would allow those 21 and older to possess, cultivate and distribute marijuana for recreational purposes. The initiative would legalize all forms of marijuana, including oils and hash,

In addition, the initiative establishes a 3-step system for marijuana expungements:

  • Step 1.) The state begins to analyze all those currently in prison with charges that would be applicable under the law and flags them for expungment.
  • Step 2.) 30 days after their release from prison, the state shall automatically expunge their records.
  • Step 3.) The state then has 10 additional days to send via certified mail notification of such an event occurring.

 

If that state fails to expunge a record that qualifies, the person has a right to a court appeal. If the person wins the court appeal, they can sue the state for fiscal damages with the state waiving it’s sovereign immunity in the case.

For more information on Legalize ND’s initiative, click here.

The post It’s Official: North Dakota Marijuana Legalization Initiative Placed on November Ballot appeared first on TheJointBlog.

from https://thejointblog.com/its-official-north-dakota-marijuana-legalization-initiative-placed-on-november-ballot/…

Study: Legalizing Medical Marijuana Associated with a 33.7% Reduction in Workplace Fatalities Among Those Aged 25 to 44

According to a new study published by the International Journal of Drug Policy, the legalization of medical marijuana is associated with a large decrease in workplace fatalities .

According to its abstract, the aim of the study “was to determine the association between legalizing medical marijuana and workplace fatalities.” Using data from all 50 states and the District of Columbia between 1992 and 2015 (obtained from the Bureau of Labor Statistics), regression models were adjusted for state demographics, the unemployment rate, state fixed effects, and year fixed effects.

“Legalizing medical marijuana was associated with a 19.5% reduction in the expected number of workplace fatalities among workers aged 25–44”, states the study. This associated “grew stronger over time”, rising to a 33.7% reduction five years after medical marijuana legalization took effect.

Researchers found that medical marijuana laws “that listed pain as a qualifying condition or allowed collective cultivation were associated with larger reductions in fatalities among workers aged 25–44 than those that did not.”

The association between legalizing medical marijuana and workplace fatalities among workers aged 16–24, “although negative, was not statistically significant at conventional levels.”

The study concludes by stating that :The results provide evidence that legalizing medical marijuana improved workplace safety for workers aged 25–44. Further investigation is required to determine whether this result is attributable to reductions in the consumption of alcohol and other substances that impair cognitive function, memory, and motor skills.

The full study can be found by clicking here.

The post Study: Legalizing Medical Marijuana Associated with a 33.7% Reduction in Workplace Fatalities Among Those Aged 25 to 44 appeared first on TheJointBlog.

from https://thejointblog.com/study-legalizing-medical-marijuana-associated-with-a-33-7-reduction-in-workplace-fatalities-among-those-aged-25-to-44/…

Marijuana Expected to be Rescheduled Federally by the Fall

Recently the United States Food and Drug Administration (FDA), for the first time ever, gave approval to a marijuana-based medicine. The company behind the medicine now says he expects the government to reschedule cannabis within 90 days.

“We expect to make Epidiolex available to U.S. patients this fall, following rescheduling which is expected to occur within 90 days of FDA approval,” said GW Pharmarceuticals’ CEO Justin Grover in a recent earnings call. “We have been building commercial inventory in recent months and are in a position to ship product into the U.S. supply chain, once rescheduling is complete.”

In June, Epidiolex became the first marijuana-derived medicine to ever be approved by the FDA. According to Grover, roughly 1,200 people in other countries are currently receiving Epidiolex, mostly for Lennox-Gastraut and Dravet Syndromes.

If rescheduling really does occur within 90 days of the FDA’s approval of Epidiolex, the change should happen by the end of September. The most likely scenario is that marijuana will be shifted to schedule 2, which means it’s still highly regulated but does have some medical value.

The post Marijuana Expected to be Rescheduled Federally by the Fall appeared first on TheJointBlog.

from https://thejointblog.com/marijuana-expected-to-be-rescheduled-federally-by-the-fall/…

Study: CBD Helps Heal Wounds During Their Early Stages

A new study published in the jounal Phytotherapy Research has found that CBD exerts “an antiinflammatory effect in early phase of wound healing process”.

“The effects of cannabidiol (CBD), the main non-psychotropic component of Cannabis sativa, were assessed on oral wound healing in an in vivo model”, states the abstract of the study, which was epublished ahead of print by the U.S. National Institute of Health. “Standardized ulcers” were induced in 60 rats, who subsequently received “intraperitoneal injections of CBD at doses of 0 (control), 5, and 10 mg/kg daily.” Animals were weighed daily, and wound healing was clinically and histologically evaluated after 3 and 7 days of treatment.

“CBD treatment did not influence the wound area of ulcerative lesions at either observation time”, states researchers. “”Conversely, microscopic findings revealed that at Day 3 postwounding, CBD-treated lesions exhibited significantly lower inflammatory scores than those in the control group.” However, “this difference was not observed at Day 7.”

Researchers conclude by stating that “Collectively, these findings indicate that CBD exert an antiinflammatory effect in early phase of wound healing process although it was not sufficient promote clinical improvement of oral traumatic ulcerative lesions.

The full study, conducted by researchers at Pontifical Catholic University of Rio Grande and the University of São Paulo, can be found by clicking here.

The post Study: CBD Helps Heal Wounds During Their Early Stages appeared first on TheJointBlog.

from https://thejointblog.com/study-cbd-helps-heal-wounds-during-their-early-stages/…

Nearly $600 million in Legal Marijuana Sold in Denver Last Year, $44 Million in Taxes Garnered

There was almost $600 million in marijuana and marijuana products sold in Denver in 2017, resulting in tens of million of dollars in taxes for the city.

According to a new report titled The Denver Collaborative Approach: Leading The Way In Municipal Marijuana Management 2018. there was roughly $587 million in legal marijuana sold throughout Denver in 2017, a 29% increase from the year prior. $377 million of this came from recreational marijuana sales, with the remaining $210 million from the legal distribution of medical marijuana

These sales resulted in around $44 million in taxes. This marks a 20% increase from the marijuana tax revenue the city garnered in 2016.

“This new report demonstrates Denver’s coordinated approach between multiple agencies to manage marijuana is working,” said Denver’s Mayor Michael B. Hancock in a press release sent out earlier today. “We took on the daunting challenge of becoming the first major city in America to manage legalized recreational marijuana and we are having success. That’s because of coordination between Denver’s Excise and Licenses, Denver’s Fire Department, Police Department, Department of Public Health and Environment, Community Planning and Development, as well as our partners in other city agencies, the community from the marijuana industry and public health advocates.”

In Denver, marijuana has been legal since 2013, with the first legal sales taking place in January of the following year.

Denver is the most populated city in Colorado with around 690,000 residents.

The post Nearly $600 million in Legal Marijuana Sold in Denver Last Year, $44 Million in Taxes Garnered appeared first on TheJointBlog.

from https://thejointblog.com/nearly-600-million-in-legal-marijuana-sold-in-denver-last-year-44-million-in-taxes-garnered/…

Connecticut primary election will take place Tuesday, August 14

Strong contrast emerges between Democratic candidates for attorney general

The Connecticut primary election will take place next Tuesday, August 14. If you’re a Connecticut resident and you’re not sure how or where to vote, please visit the secretary of state’s website for more information.

On the Democratic ticket, both candidates for governor and both candidates for lieutenant governor have said they support taxing and regulating marijuana. However, in the race for attorney general, there is a strong contrast between the Democratic candidates’ positions. At a recent debate, former U.S. Attorney Chris Mattei spoke strongly in favor of regulating marijuana, while the other two candidates, state Rep. William Tong and state Sen. Paul Doyle, “expressed reservations.” Additionally, Mattei has criticized Tong for his failure to support the medical cannabis bill when it passed in 2012.

None of the five Republican candidates for governor have spoken publicly in favor of ending marijuana prohibition.

The post Connecticut primary election will take place Tuesday, August 14 appeared first on MPP Blog.

from https://blog.mpp.org/tax-and-regulate/connecticut-primary-election-will-take-place-tuesday-august-14/…

Study: 80% of Autistic Children Saw Improvements Afer Consuming CBD

In a new study published by the journal Neurology, 80% of children with autism saw improvements in their condition after being administered cannabidiol (CBD).

For the study, 60 children with an average age of 12 were given cannabis oil containing 20% CBD and 1% THC, for a period of seven months.

After the seven-month period, children filled out a questionnaire asking  if they noticed any changes in their condition. Parents were asked if they noticed any changes in their child’s condition, and were asked about any changes in their child’s anxiety levels and communication abilities.

According to the study’s lead Dr. Adi Aran, director of the pediatric neurology unit at Shaare Zedek Hospital in Jerusalem, 80% of parents reported a decrease in problematic behavior following the use of CBD, and 62% reported that their child’s behavior improved significantly. Around half of the children claimed they noticed improvements in their communication, and 40% saw significant improvements in their anxiety symptoms.

“According to the astonishing report, eighty percent of the children reported improved functioning!”, says Nachshol Cohen, Founder of Cannabium. “We hope that this research will help to bring about a conceptual change by regulators and policymakers, which will lead to a scientific momentum that will unequivocally demonstrate the positive effects of cannabis on a variety of health problems.”

The study also found that half of the children who participated in the study also reported an improvement in their level of communication, with 40% saying that their anxiety symptoms had significantly improved. A third of the participants did not show symptoms of anxiety before the study began.

The post Study: 80% of Autistic Children Saw Improvements Afer Consuming CBD appeared first on TheJointBlog.

from https://thejointblog.com/study-80-of-autistic-children-saw-improvements-afer-consuming-cbd/…

Florida Judge Rules Limit on Medical Cannabis Businesses is Unconstitutional

A circuit court judge in Florida has ruled that the state’s limit on medical cannabis businesses is unconstitutional as it runs contrary to the intent of the voter-approved initiative that legalized the medicine.

Leon County Circuit Judge Charles Dodson ruled that an arbitrary cap on medical marijuana treatment centers, passed by state lawmakers in 2017, “directly contradicts the amendment” that legalized medical cannabis.

“Such limits directly undermine the clear intent of the amendment, which by its language seeks to prevent arbitrary restriction on the number of MMTCs authorized to conduct business in the state”, Dodson wrote in his ruling. “The amendment mandates the availability and safe use of medical marijuana by qualifying patients”.

Dodson also ruled that the state’s requirement of “vertical integration” is unconstitutional.

“It’s the first time any judge has weighed in on the licensing process at all, and what he said was unequivocal”, says Florigrown CEO Adam Eland. “What he’s saying, and I think this is super clear, is what you’re doing is unconstitutional”.

The post Florida Judge Rules Limit on Medical Cannabis Businesses is Unconstitutional appeared first on TheJointBlog.

from https://thejointblog.com/florida-judge-rules-limit-on-medical-cannabis-businesses-is-unconstitutional/…

California: Medical Cannabis for Pets Bill Passed by Assembly, Advances in Senate

Legislation to explicitly allow and regulate the medical use of cannabis for pets is advancing in the California Legislature.

California Assembly Bill 2215 would expand “the intent of the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) to control and regulate cannabis and cannabis products for medicinal use on pets.” The bill would define “cannabis products” to include products intended for medicinal use on a pet. The bill wouldn’t allow a veterinarian to administer medical cannabis, “but allow a veterinarian to discuss the use of cannabis on an animal for medicinal purposes without being disciplined or denied, revoked or suspended by the Veterinary Medical Board (VMB). ”

The measure states that the VMB “would have until July 1, 2019 to promulgate guidelines for veterinarians to follow when discussing the use of cannabis”, and it “Provides that a cannabis product for use on a pet may only be sold to an adult 21 years or age or over by a licensee who has been issued a retailer license, as specified.”

The proposal quietly passed the Assembly at the end of May in a 60 to 10 vote. Yesterday in the Senate Appropriations Committee it was “ordered to second reading pursuant to Senate Rule 28.8.”

If the bill is passed by the full Senate, it will be sent to Governor Jerry Brown for consideration.

The full text of Assembly Bill 2215 can be found by clicking here.

The post California: Medical Cannabis for Pets Bill Passed by Assembly, Advances in Senate appeared first on TheJointBlog.

from https://thejointblog.com/california-medical-cannabis-for-pets-bill-passed-by-assembly-advances-in-senate/…

Proposed US Tariffs Threaten Vaporizer Industry

The Blinc Group’s Arnaud d Dumas Rauly: “The cannabis industry will suffer from these tariffs.”

The US vaporizer industry is in a panic over proposed 25% tariffs on Chinese products. This would affect pen devices, hardware and batteries. China dominates the worldwide vaporizer hardware market.

“The rationale behind this administration’s trade war against China is twofold: stealing American jobs and stealing American IP and know-how,” Arnaud Dumas de Rauly, co-founder and co-CEO of the New York-based vape company, The Blinc Group, tells Freedom Leaf. “However, as it pertains to vaping products, none of these jobs and know-how are in the US to begin with. The cannabis industry will suffer from these tariffs.

“The supply of raw material isn’t big enough in the US to support a switch to US manufacturing,” he continues. “The skillsets aren’t in the US either. Bottom line, these tariffs will not bring jobs to America. In addition, given the small margins (10-15%) on the hardware, the cost of these tariffs will be passed on to consumers, which will limit patient/consumer access to cannabis products, especially in states like Florida and New York, whose medical programs relay on vaping products. Finally, the regulatory uncertainty is already stifling the cannabis industry, so this trade war will be adding ‘federal action’ onto already struggling businesses. It just doesn’t make sense, not to mention the loss of taxes on a state level that will result from the limited access.”

ARNAUD DE DUMAS RAULY: “These proposed tariff increases will do great harm to American businesses, medical marijuana patients and adult use consumers.”

On July 24, Dumas de Rauly testified at public hearings conducted by The Office of the U.S. Trade Representative regarding proposed tariffs on $16 billion worth of Chinese products.

Report: Drug Legalization Would Add $100 Billion to U.S. Budget

Ending the drug war would result in an additional $100 billion annually for the U.S. budget, according to a new report conducted by The Cato Institute.

“Drawing on the most recent available data, this bulletin estimates the fiscal windfall that would be achieved through drug legalization”, states the report. “All told, drug legalization could generate up to $106.7 billion in annual budgetary gains for federal, state, and local governments.” Those gains would come from two primary sources: decreases in drug enforcement spending and increases in tax revenue.

The report estimates that “state and local governments spend $29 billion on drug prohibition annually, while the federal government spends an additional $18 billion.” Meanwhile, “full drug legalization would yield $19 billion in state and local tax revenue and $39 billion in federal tax revenue.

“Legalization can reduce government spending, which saves resources for other uses, and it generates tax revenue that transfers income from drug producers and consumers to public coffers,”  Jeffrey Miron, the institute’s Director of Economic Studies, states in the report.

The full report can be found by clicking here.

The post Report: Drug Legalization Would Add $100 Billion to U.S. Budget appeared first on TheJointBlog.

from https://thejointblog.com/report-drug-legalization-would-add-100-billion-to-u-s-budget/…

Rohrabacher Received Campaign Donations from Manafort, Had Meetings with Assange and Butina

Rep. Dana Rohrabacher (R-Calif.) may be a friend to marijuana legalization, but that’s where his liberal leanings stop. The Congressman is a major backer of Donald Trump and has been implicated in Russian meddling in the 2016 presidential campaign.

Though his name has not been mentioned so far in special counsel Robert Mueller’s investigation into Russia’s interference in the election, it’s now known that Rohrabacher attended a 2013 meeting with former Trump campaign chairman Paul Manafort, who’s been indicted by the special counsel.

Rohrabacher, Manafort and former Rep. Vin Weber, a Minnesota Republican who’s now a lobbyist with Mercury, were at the meeting on Mar. 19, 2013, which was disclosed in retroactive filings with the Justice Department last year that detailed Manafort and Rick Gates’ work for the European Center for a Modern Ukraine. Gates, a former Trump campaign aide and Manafort associate, pled guilty on Feb. 23 to felony charges of conspiracy and making false statements in a plea bargain with Mueller.

Gates lied about the 2013 meeting and his Ukraine-related work with Manafort. He’s charged with “admitting to take part in a conspiracy to hide tens of millions of dollars that he and former Trump campaign chairman Paul Manafort obtained from their consulting work related to Ukraine.” Gates later helped Manafort prepare “a report that memorialized for Ukrainian leadership the pertinent Ukraine discussions that Manafort represented had taken place at the meeting.”

Illinois Governor Signs Bill Allowing Medical Cannabis to be Consumed at Schools

Illinois Governor Bruce Rauner has signed into law a bill allowing students who are medical cannabis patients to use their medicine on school premises.

Governor Rauner’s signing of House Bill 4870 comes roughly two and a half months after the legislature passed the measure by a vote of 149 to 3.

The legislation is known as Ashley’s Law, named after 12-year-old Ashley Surin who uses medical marijuana to treat the epilepsy she developed during chemotherapy. The  bill amends the Illinois School Code to require “a school district, public school, charter school, or nonpublic school to authorize a parent or guardian of a student who is a qualifying patient to administer a medical cannabis infused product to the student on school premises or a school bus if both the student (as a qualifying patient) and the parent or guardian (as a designated caregiver) have been issued registry identification cards under the Compassionate Use of Medical Cannabis Pilot Program Act.”

The measure  “Provides that a parent or guardian may not administer a medical cannabis infused product if the administration would create disruption to the school’s educational environment or would cause exposure of the product to other students”, and “Provides that nothing in the provision requires a member of the school’s staff to administer a medical cannabis infused product to a student.”

An amendment  passed by the House states:

Provides that the provision may be referred to as Ashley’s Law. Defines terms. Provides that, in addition to the parent or guardian of a student who is a registered qualifying patient, an individual registered with the Department of Public Health as a designated caregiver may administer a medical cannabis infused product to that student. Makes conforming changes. Provides that a parent or guardian or other individual may not administer a medical cannabis infused product in a manner that, in the opinion of the school district or school, would create a disruption to the

Illinois Governor Signs Bill Allowing Medical Cannabis to be Consumed at Schools

Illinois Governor Bruce Rauner has signed into law a bill allowing students who are medical cannabis patients to use their medicine on school premises.

Governor Rauner’s signing of House Bill 4870 comes roughly two and a half months after the legislature passed the measure by a vote of 149 to 3.

The legislation is known as Ashley’s Law, named after 12-year-old Ashley Surin who uses medical marijuana to treat the epilepsy she developed during chemotherapy. The  bill amends the Illinois School Code to require “a school district, public school, charter school, or nonpublic school to authorize a parent or guardian of a student who is a qualifying patient to administer a medical cannabis infused product to the student on school premises or a school bus if both the student (as a qualifying patient) and the parent or guardian (as a designated caregiver) have been issued registry identification cards under the Compassionate Use of Medical Cannabis Pilot Program Act.”

The measure  “Provides that a parent or guardian may not administer a medical cannabis infused product if the administration would create disruption to the school’s educational environment or would cause exposure of the product to other students”, and “Provides that nothing in the provision requires a member of the school’s staff to administer a medical cannabis infused product to a student.”

An amendment  passed by the House states:

Provides that the provision may be referred to as Ashley’s Law. Defines terms. Provides that, in addition to the parent or guardian of a student who is a registered qualifying patient, an individual registered with the Department of Public Health as a designated caregiver may administer a medical cannabis infused product to that student. Makes conforming changes. Provides that a parent or guardian or other individual may not administer a medical cannabis infused product in a manner that, in the opinion of the school district or school, would create a disruption to the

Study: THC May Treat Agitation In Alzheimer’s Patients

The administration of nabilone, a synthetic compound meant to mimic the effects of  natural THC, reduces agitation and other behavioral symptoms in Alzheimer’s patients, according to new research.

“Results of a randomized, double-blind clinical trial suggest that nabilone — a synthetic cannabinoid — may be effective in treating agitation in people with Alzheimer’s disease”, states a press release for the study, which was presented at the Alzheimer’s Association International Conference (AAIC) 2018.

“Agitation, including verbal or physical outbursts, general emotional distress, restlessness, pacing, is one of the most common behavioral changes associated with Alzheimer’s as it progresses, and can be a significant cause of caregiver stress,” said Krista L. Lanctôt, PhD, Senior Scientist at Sunnybrook Health Sciences Centre and Professor of Psychiatry and Pharmacology/Toxicology at the University of Toronto.

Lanctôt and colleagues investigated the potential benefits of nabilone for adults with moderate to severe Alzheimer’s dementia with clinically significant agitation. Over the 14-week trial duration, 39 participants (77 percent male, average age 87) received nabilone in capsule form (mean therapeutic dose=1.6 +/- .5 mg) for six weeks, followed by six weeks of placebo, with one week between each treatment period. In addition to measuring agitation, the researchers assessed overall behavioral symptoms, memory, physical changes and safety. They found that:

  • Agitation improved significantly in those taking nabilone, compared to placebo, as measured by the Cohen-Mansfield Agitation Inventory (p=0.003).
  • Nabilone also significantly improved overall behavioral symptoms, compared to placebo, as measured by the Neuropsychiatric Inventory (p=0.004).

 

The researchers also observed small benefits in cognition and nutrition during the study. More people in the study experienced sedation on nabilone (45 percent) compared to placebo (16 percent).

“Currently prescribed treatments for agitation in Alzheimer’s do not work in everybody, and when they do work the effect is small and they increase risk of harmful side effects, including increased risk of death. As a result, there is an urgent need …

Alaska Garnered Over $11 Million in Taxes from Legal Marijuana Sales in FY 2018

According to data released by the Alaska Department of Revenue, the state earned over $11 million in taxes from the sale of marijuana and marijuana products in FY 2018.

In total, Alaska made $11,094,808 in tax revenue from marijuana sales during FY (fiscal year) 2018. This surpasses the Department of Revenue’s predictions for the year by around $2 million.

The highest earning month for FY 2018, which began on July 1, 2017 with the final day being June 31 of this year, was June with $1,257,513 in marijuana taxes brought  in. The lowest month was July at $577,901.

In Alaska, marijuana was legalized through a citizen’s initiative in 2014, with those 21 and  older allowed to purchase, possess and use up to an ounce (with the possession limit rising to four ounces when in a private residence). The state’s first licensed marijuana retail outlet opened nearly two years later in October, 2016.

Under the state’s law, marijuana is taxed at $50 per ounce for bud, and $15 per ounce for leaves and other trimmings.

The post Alaska Garnered Over $11 Million in Taxes from Legal Marijuana Sales in FY 2018 appeared first on TheJointBlog.

from https://thejointblog.com/alaska-garnered-over-11-million-in-taxes-from-legal-marijuana-sales-in-fy-2018/…

Study: 75% of Physicians in New York Have Patients Who Use Medical Cannabis, Neuropathy the Most Common Qualifying Condition

According to a new study more than seven out of every 10 physicians in New York have patients who use medical cannabis, with the most common qualifying condition being neuropathy.

The study of practicing physicians, MDs or DOs, in New York found that “More than 75% reported having patients who used cannabis for symptom control, and 50% reported having patients who inquired about MMJ [medical marijuana] within the past year”. The majority (71%) agreed that “MMJ should be an option available to patients”.

The study found that the most common qualifying medical condition among medical cannabis patients to be neuropathy, followed closely by cancer, epilepsy, multiple sclerosis and Parkinson’s disease.

Among the medical professionals who have patients using the plant for symptom contol, the most common symptoms were “pain (83%), anxiety (54.7%), nausea (46.2%), depression (37.1%), cachexia (31.1%), and 17.9% for other indications, including for spasticity, sleep issues, and seizures.

For the study, which was published the National Institute of Health’s official website. “A 30-item questionnaire was developed by our research team based on surveys developed by others, but adapted to NY-specific needs (Supplementary Data—Survey).” This survey “sought to obtain perspectives on the NY-MMP from practicing physicians. Survey questions included categorical/nominal, ordinal, and continuous data.”

Survey responses from close-ended questions were sorted and analyzed using Survey Monkey and Excel, and Prism statistical software. Responses from open-ended questions were analyzed through thematic categorization and frequency analysis.

The full text of the study can be found by clicking here.

The post Study: 75% of Physicians in New York Have Patients Who Use Medical Cannabis, Neuropathy the Most Common Qualifying Condition appeared first on TheJointBlog.

from https://thejointblog.com/study-75-of-physicians-in-new-york-have-patients-who-use-medical-cannabis-neuropathy-the-most-common-qualifying-condition/…

Medical marijuana initiative filed in Mississippi

Yesterday, Mississippians for Compassionate Care filed an initiative with the Secretary of State’s office that would make medical marijuana legal in Mississippi. The group is aiming to bring an amendment to the state constitution to voters in 2020. The first step to getting it on the ballot is to collect over 100,000 signatures from all over the state. You can read the proposed amendment here.

The signature collection is a huge undertaking and the campaign will need lots of volunteers to circulate petitions in their area. If you are a Mississippi resident who is willing to help collect signatures, please email the signature collection coordinator: JB Brown.

For more information on the campaign or to get involved, please go to www.medicalmarijuana2020.com. It’s time for patients suffering in Mississippi to have access to medical marijuana.

The post Medical marijuana initiative filed in Mississippi appeared first on MPP Blog.

from https://blog.mpp.org/medical-marijuana/medical-marijuana-initiative-filed-in-mississippi/…

How To Use A One Hitter And Why You Should Get One

one_hitter_1

A one hitter is a small pipe with a narrow bowl that is designed and used for a single inhalation, or one hit. It typically holds about 25 milligrams of cannabis (a single hit). Although you may be most familiar with the one hitter that looks like a cigarette, there are actually a few different traditional styles of one hitter pipes.

one hitterSource: dhgate.com

Traditional Styles Of One Hitter Pipes

Kiseru

The kiseru is a Japanese pipe typically made of metal and bamboo — metal for the mouthpiece and bowl with bamboo in between. Kiseru became popular in the 17th century and can even be found mentioned in some Buddhist textbooks.

Midwakh

MidwakhSource: turbosquid.com

The midwakh is a Middle Eastern pipe that is traditionally used to smoke tobacco mixed with herbs. These one hitter pipes are mostly produced in the United Arab Emirates and can be made out of a multitude of materials, including wood, bone, metal, or glass.

Sebsi

A sebsi is a Moroccan pipe with a narrow clay bowl. The stem is made of wood and has been traditionally used to smoke cannabis pollen, or kief. They can be up to 18 inches long.

Chillum

chillumSource: karmagroupindia.com

Chillums are straight, conical one hitter pipes that feature a channel connected from end to end. They are typically made of clay and have been in use since the 18th century. Originally, chillums were smoked by hindu monks in India, but they have made their popularity has now spread across the world.

How Do You Use A One Hitter?

One hitter pipes are easy to use. You fill the narrow chamber or bowl with your weed, pack it in tightly, light up, and take a puff. Inhale slowly but steadily to get the best hit and avoid pulling in ash. There are some techniques you can use to make using a one hitter more enjoyable, though.

Use The Right Consistency